• China Nuokang Bio-Pharmaceutical Inc., of Beijing, said the independent committee of the company's board of directors evaluating the acquisition proposal from Chairman and CEO Baizhong Xue appointed Lazard and Houlihan Lokey as its independent financial advisors. In May, Xue proposed to acquire the outstanding shares not currently owned by Xue or companies under his control.